Concussion Post Syndrome Recruiting Phase 0 Trials for Magnesium oxide (DB01377)

IndicationStatusPhase
DBCOND0093446 (Concussion Post Syndrome)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs